Gene polymorphisms in primary biliary cirrhosis: association with the disease and hepatic osteopathy
暂无分享,去创建一个
[1] J. Kanis,et al. DIAGNOSIS OF OSTEOPOROSIS , 2016 .
[2] P. Donaldson,et al. Genetic factors in the pathogenesis of primary biliary cirrhosis. , 2003, Clinics in liver disease.
[3] P. Lakatos,et al. High serum osteoprotegerin and low RANKL in primary biliary cirrhosis. , 2003, Journal of hepatology.
[4] A. Morabito,et al. Peculiar HLA polymorphisms in Italian patients with primary biliary cirrhosis. , 2003, Journal of hepatology.
[5] I. Kawamura,et al. Serum insulinlike growth factor-I in biliary atresia. , 2003, Journal of pediatric surgery.
[6] S. Krane,et al. Mutation in collagen‐I that confers resistance to the action of collagenase results in failure of recovery from CCl4‐induced liver fibrosis, persistence of activated hepatic stellate cells, and diminished hepatocyte regeneration , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[7] A. Uitterlinden,et al. Collagen Ia1 Polymorphism is Associated with Bone Characteristics in Caucasian Children and Young Adults , 2002, Calcified Tissue International.
[8] K. Sjögren,et al. Effects of Liver‐Derived Insulin‐Like Growth Factor I on Bone Metabolism in Mice , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[9] D. Leroith,et al. Circulating levels of IGF-1 directly regulate bone growth and density. , 2002, The Journal of clinical investigation.
[10] M. Pines,et al. Halofuginone, a collagen type I inhibitor improves liver regeneration in cirrhotic rats. , 2002, Journal of hepatology.
[11] P. Lakatos,et al. Vitamin D receptor, oestrogen receptor-alpha gene and interleukin-1 receptor antagonist gene polymorphisms in Hungarian patients with primary biliary cirrhosis , 2002, European journal of gastroenterology & hepatology.
[12] M. Manns,et al. Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitis , 2002, Hepatology.
[13] D. Reid,et al. COL1A1 Sp1 Polymorphism Predicts Perimenopausal and Early Postmenopausal Spinal Bone Loss , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[14] J. Ioannidis,et al. Association of Collagen Iα 1 Sp1 Polymorphism with the Risk of Prevalent Fractures: A Meta‐Analysis , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[15] O. Chazouilleres,et al. Apolipoprotein E polymorphism, a marker of disease severity in primary biliary cirrhosis? , 2001, Journal of hepatology.
[16] J. Prieto,et al. Antifibrogenic effect in vivo of low doses of insulin-like growth factor-I in cirrhotic rats. , 2001, Biochimica et biophysica acta.
[17] R M Aspden,et al. A COL1A1 Sp1 binding site polymorphism predisposes to osteoporotic fracture by affecting bone density and quality. , 2001, The Journal of clinical investigation.
[18] W. Blum,et al. Circulating levels of insulin-like growth factors and their binding proteins in patients with chronic liver disease: lack of correlation with bone mineral density. , 2001, Liver.
[19] P. Lakatos,et al. [Follow-up study of bone mineral density in postmenopausal patients with primary biliary cirrhosis]. , 2001, Orvosi hetilap.
[20] P. Donaldson,et al. HLA and interleukin 1 gene polymorphisms in primary biliary cirrhosis: associations with disease progression and disease susceptibility , 2001, Gut.
[21] F. Rivera,et al. Collagen type Iα1 and vitamin D receptor gene polymorphisms and bone mass in primary biliary cirrhosis , 2001 .
[22] D. Reid,et al. Estrogen Receptor α Gene Polymorphisms and Bone Mineral Density: Haplotype Analysis in Women from the United Kingdom , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[23] M. Taniyama,et al. Vitamin D receptor gene polymorphism is associated with Graves' disease in the Japanese population. , 2000, The Journal of clinical endocrinology and metabolism.
[24] S. Kikuchi,et al. Estrogen receptor gene polymorphism in Japanese patients with multiple sclerosis , 2000, Journal of the Neurological Sciences.
[25] A. Berghold,et al. Association of the Vitamin D Receptor Genotype BB with Low Bone Density in Hyperthyroidism , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[26] P. Lakatos,et al. Lack of association between interleukin-1 receptor antagonist protein gene polymorphism and bone mineral density in Hungarian postmenopausal women. , 2000, Bone.
[27] C. Rosen. IGF-I and osteoporosis. , 2000, Clinics in laboratory medicine.
[28] B. Halmos,et al. Association of Primary Biliary Cirrhosis with Vitamin D Receptor BsmI Genotype Polymorphism in a Hungarian Population , 2000, Digestive Diseases and Sciences.
[29] A. Ho,et al. PvuII Polymorphisms of the Estrogen Receptor α and Bone Mineral Density in Healthy Southern Chinese Women , 2000, Calcified Tissue International.
[30] M. Evans,et al. Molecular mechanisms involved in the estrogen-dependent regulation of calcineurin in systemic lupus erythematosus T cells. , 2000, Clinical immunology.
[31] R. Honkanen,et al. Early Postmenopausal Bone Loss Is Associated with PvuII Estrogen Receptor Gene Polymorphism in Finnish Women: Effect of Hormone Replacement Therapy , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[32] Y. Bagger,et al. No major effect of estrogen receptor gene polymorphisms on bone mineral density or bone loss in postmenopausal Danish women. , 2000, Bone.
[33] I. Okan,et al. Serum Concentrations of Insulin-like Growth Factor-I and Insulin-like Growth Factor Binding Protein-3 in Patients with Chronic Hepatitis , 2000, Scandinavian journal of gastroenterology.
[34] Daniel L. Koller,et al. Sibling pair linkage and association studies between bone mineral density and the insulin-like growth factor I gene locus. , 1999, The Journal of clinical endocrinology and metabolism.
[35] P. Geusens,et al. Lack of association between estrogen receptor genotypes and bone mineral density, fracture history, or muscle strength in elderly women. , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[36] R. Fox,et al. Estrogen in autoimmunity: expression of estrogen receptors in thymic and autoimmune T cells. , 1999, The journal of gender-specific medicine : JGSM : the official journal of the Partnership for Women's Health at Columbia.
[37] C. Rosen,et al. Serum insulin-like growth factors and insulin-like growth factor-binding proteins: clinical implications. , 1999, Clinical chemistry.
[38] F. Vleggaar,et al. Prevention and treatment of osteoporosis in primary biliary cirrhosis. , 1999, European journal of gastroenterology & hepatology.
[39] H. Whittle,et al. Tuberculosis and chronic hepatitis B virus infection in Africans and variation in the vitamin D receptor gene. , 1999, The Journal of infectious diseases.
[40] S. Pereira,et al. Non-invasive assessment of bone density in primary biliary cirrhosis. , 1999, European journal of gastroenterology & hepatology.
[41] J. Féher,et al. Significant differences in the interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms in a Hungarian population with inflammatory bowel disease. , 1999, Scandinavian journal of gastroenterology.
[42] Mark L. Johnson,et al. Change of bone mass in postmenopausal Caucasian women with and without hormone replacement therapy is associated with vitamin D receptor and estrogen receptor genotypes , 1998, Human Genetics.
[43] Clavreul,et al. Vitamin D differentially regulates B7.1 and B7.2 expression on human peripheral blood monocytes , 1998, Immunology.
[44] T. Spector,et al. Allelic variation at the interleukin-1 receptor antagonist gene is associated with early postmenopausal bone loss at the spine. , 1998, Bone.
[45] J. Bilezikian,et al. Association between serum insulin growth factor-I (IGF-I) and a simple sequence repeat in IGF-I gene: implications for genetic studies of bone mineral density. , 1998, The Journal of clinical endocrinology and metabolism.
[46] C. Bunten,et al. Bone Mineral Density and Its Change in White Women: Estrogen and Vitamin D Receptor Genotypes and Their Interaction , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[47] E. G. de la Concha,et al. Combined effect of HLA-DRB1*1501 and interleukin-1 receptor antagonist gene allele 2 in susceptibility to relapsing/remitting multiple sclerosis , 1997, Journal of Neuroimmunology.
[48] R. Coppel,et al. In situ nucleic acid hybridization of cytokines in primary biliary cirrhosis: Predominance of the Th1 subset , 1997, Hepatology.
[49] J. Rodés,et al. Osteoporosis and Bone Mineral Metabolism Disorders in Cirrhotic Patients Referred for Orthotopic Liver Transplantation , 1997, Calcified Tissue International.
[50] G. Cooper,et al. Are vitamin D receptor polymorphisms associated with bone mineral density? A meta‐analysis , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[51] K. Tsai,et al. Bone mineral density and bone markers in relation to vitamin D receptor gene polymorphisms in Chinese men and women. , 1996, Bone.
[52] S. Grant,et al. Reduced bone density and osteoporosis associated with a polymorphic Sp1 binding site in the collagen type I α 1 gene , 1996, Nature Genetics.
[53] P. Delmas,et al. Vitamin D receptor gene polymorphisms are not related to bone turnover, rate of bone loss, and bone mass in postmenopausal women: The OFELY study , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[54] Y. Ouchi,et al. Association of bone mineral density with polymorphism of the estrogen receptor gene , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[55] G. Siest,et al. Segregation analysis and variance components analysis of bone mineral density in healthy families , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[56] B. Dawson-Hughes,et al. The BsmI vitamin D receptor restriction fragment length polymorphism (BB) predicts low bone density in premenopausal black and white women , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[57] J. Lemire. Immunomodulatory actions of 1,25-Dihydroxyvitamin D3 , 1995, The Journal of Steroid Biochemistry and Molecular Biology.
[58] E. Dickson,et al. Bone disease in primary biliary cirrhosis: Does ursodeoxycholic acid make a difference? , 1995, Hepatology.
[59] D. Grennan,et al. Cytokine production by normal human monocytes: inter‐subject variation and relationship to an IL‐1 receptor antagonist (IL‐1Ra) gene polymorphism , 1995, Clinical and experimental immunology.
[60] K. Korach. Insights from the study of animals lacking functional estrogen receptor. , 1994, Science.
[61] B. Riggs,et al. Circulating cytokine levels in osteoporotic and normal women. , 1994, The Journal of clinical endocrinology and metabolism.
[62] J. Eisman,et al. Prediction of bone density from vitamin D receptor alleles , 1994, Nature.
[63] E. Dickson,et al. Rates of cancellous bone remodeling and turnover in osteopenia associated with primary biliary cirrhosis. , 1993, Bone.
[64] A. Blakemore,et al. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat , 1993, Human Genetics.
[65] L. Bonewald,et al. Interleukin‐1 receptor antagonist inhibits the hypercalcemia mediated by interleukin‐1 , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[66] F. Rivera,et al. Factors influencing the development of metabolic bone disease in primary biliary cirrhosis. , 1990, The American journal of gastroenterology.
[67] J. Hopper,et al. Genetic determinants of bone mass in adults. A twin study. , 1987, The Journal of clinical investigation.
[68] M. Kaplan,et al. Primary Biliary Cirrhosis , 1987, The New England journal of medicine.
[69] S. Arnaud. 25-Hydroxyvitamin D3 treatment of bone disease in primary biliary cirrhosis. , 1982, Gastroenterology.
[70] Z. Varghese,et al. Clinical, biochemical, and histological studies of osteomalacia, osteoporosis, and parathyroid function in chronic liver disease. , 1978, Gut.
[71] R. Kalluri,et al. Liver fibrosis: insights into migration of hepatic stellate cells in response to extracellular matrix and growth factors. , 2003, Gastroenterology.
[72] E. Martín Mola,et al. Polymorphism in the type I collagen (COLIA1) gene and risk of fractures in postmenopausal women. , 2002, Bone.
[73] F. Rivera,et al. Collagen type Ialpha1 and vitamin D receptor gene polymorphisms and bone mass in primary biliary cirrhosis. , 2001, Hepatology.
[74] D. Cole,et al. Vitamin D-receptor genotypes as independent genetic predictors of decreased bone mineral density in primary biliary cirrhosis. , 2000, Gastroenterology.
[75] S. Saitoh,et al. Correlation of a polymorphism in the interleukin-1 receptor antagonist gene with hepatic fibrosis in Japanese alcoholics. , 1998, Alcoholism, clinical and experimental research.
[76] C. Gabay,et al. Interleukin-1 receptor antagonist: role in biology. , 1998, Annual review of immunology.
[77] A. Blakemore,et al. Association of Graves' disease with an allele of the interleukin-1 receptor antagonist gene. , 1995, The Journal of clinical endocrinology and metabolism.
[78] E. Dickson,et al. Hepatic osteodystrophy in primary biliary cirrhosis: effects of medical treatment. , 1994, The American journal of gastroenterology.
[79] J. Compston,et al. Low bone turnover state in primary biliary cirrhosis , 1987, Hepatology.
[80] J. Talwalkar,et al. For Personal Use. Only Reproduce with Permission from the Lancet Primary Biliary Cirrhosis , 2022 .